Defibrotide treatment but not prophylaxis is useful in hepatic sinusoidal obstruction syndrome in children undergoing autologous stem cell transplant following high‐dose chemotherapy: A single‐center experience from the Royal Marsden Hospital, UK

Nirmalya Roy Moulik, Indranee Johnson, Lucia Van Bruggen, Toni Petterson, Julie Mycroft, Sucheta J. Vaidya

Open source

DOI
10.1002/pbc.28677
Published
2020-08-31
Container
Pediatric Blood & Cancer
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/pbc.28677,
  title = {Defibrotide treatment but not prophylaxis is useful in hepatic sinusoidal obstruction syndrome in children undergoing autologous stem cell transplant following high‐dose chemotherapy: A single‐center experience from the Royal Marsden Hospital, UK},
  author = {Nirmalya Roy Moulik and Indranee Johnson and Lucia Van Bruggen and Toni Petterson and Julie Mycroft and Sucheta J. Vaidya},
  year = {2020},
  journal = {Pediatric Blood \& Cancer},
  doi = {10.1002/pbc.28677},
  url = {https://doi.org/10.1002/pbc.28677}
}

RIS

TY  - JOUR
TI  - Defibrotide treatment but not prophylaxis is useful in hepatic sinusoidal obstruction syndrome in children undergoing autologous stem cell transplant following high‐dose chemotherapy: A single‐center experience from the Royal Marsden Hospital, UK
AU  - Nirmalya Roy Moulik
AU  - Indranee Johnson
AU  - Lucia Van Bruggen
AU  - Toni Petterson
AU  - Julie Mycroft
AU  - Sucheta J. Vaidya
PY  - 2020
JO  - Pediatric Blood & Cancer
DO  - 10.1002/pbc.28677
UR  - https://doi.org/10.1002/pbc.28677
ER  - 

APA

Moulik, N. R., Johnson, I., Bruggen, L. V., Petterson, T., Mycroft, J., & Vaidya, S. J. (2020). Defibrotide treatment but not prophylaxis is useful in hepatic sinusoidal obstruction syndrome in children undergoing autologous stem cell transplant following high‐dose chemotherapy: A single‐center experience from the Royal Marsden Hospital, UK. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.28677

Source records